SCA
LLY icon

Sippican Capital Advisors’s Eli Lilly LLY Stock Holding History

Sippican Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.32M Sell
2,769
-55
-2% -$56.2K 2.03% 8
2026
Q1 		$2.6M Sell
2,824
-175
-6% -$177K 1.78% 17
2025
Q4 		$3.22M Sell
2,999
-163
-5% -$156K 2.07% 9
2025
Q3 		$2.41M Buy
3,162
+35
+1% +$26K 1.59% 19
2025
Q2 		$2.44M Sell
3,127
-20
-0.6% -$15.5K 1.77% 15
2025
Q1 		$2.6M Sell
3,147
-243
-7% -$202K 1.96% 11
2024
Q4 		$2.62M Sell
3,390
-54
-2% -$44.7K 1.91% 11
2024
Q3 		$3.05M Sell
3,444
-25
-0.7% -$22.5K 2.13% 9
2024
Q2 		$3.14M Sell
3,469
-117
-3% -$93.6K 2.49% 5
2024
Q1 		$2.79M Sell
3,586
-1,091
-23% -$776K 2.17% 9
2023
Q4 		$2.73M Buy
4,677
+841
+22% +$491K 2.14% 7
2023
Q3 		$2.06M Sell
3,836
-285
-7% -$147K 1.86% 12
2023
Q2 		$1.93M Sell
4,121
-184
-4% -$77.2K 1.78% 13
2023
Q1 		$1.48M Sell
4,305
-150
-3% -$50.6K 1.41% 24
2022
Q4 		$1.63M Buy
4,455
+6
+0.1% +$2.13K 1.56% 19
2022
Q3 		$1.44M Sell
4,449
-94
-2% -$29.8K 1.5% 24
2022
Q2 		$1.47M Sell
4,543
-948
-17% -$285K 1.46% 24
2022
Q1 		$1.57M Sell
5,491
-135
-2% -$34.7K 1.31% 31
2021
Q4 		$1.55M Sell
5,626
-30
-0.5% -$7.61K 1.32% 31
2021
Q3 		$1.31M Sell
5,656
-160
-3% -$39.5K 1.13% 34
2021
Q2 		$1.33M Sell
5,816
-20
-0.3% -$4.02K 1.16% 35
2021
Q1 		$1.09M Sell
5,836
-138
-2% -$27K 1.01% 37
2020
Q4 		$1.01M Sell
5,974
-390
-6% -$58.2K 1.09% 39
2020
Q3 		$942K Buy
6,364
+50
+0.8% +$7.74K 1.17% 34
2020
Q2 		$1.04M Sell
6,314
-1,021
-14% -$157K 1.4% 28
2020
Q1 		$1.02M Sell
7,335
-1,144
-13% -$157K 1.66% 21
2019
Q4 		$1.11M Sell
8,479
-1
-0% -$116 1.24% 30
2019
Q3 		$948K Sell
8,480
-635
-7% -$70.7K 1.15% 31
2019
Q2 		$1.01M Sell
9,115
-716
-7% -$84.3K 1.19% 29
2019
Q1 		$1.28M Sell
9,831
-2,714
-22% -$330K 1.52% 20
2018
Q4 		$1.45M Sell
12,545
-1,235
-9% -$138K 1.96% 15
2018
Q3 		$1.52M Sell
13,780
-1,842
-12% -$184K 1.75% 20
2018
Q2 		$1.33M Sell
15,622
-875
-5% -$71.9K 1.33% 30
2018
Q1 		$1.28M Buy
16,497
+11
+0.1% +$886 1.32% 29
2017
Q4 		$1.39M Sell
16,486
-100
-0.6% -$8.51K 1.36% 31
2017
Q3 		$1.42M Sell
16,586
-625
-4% -$51.3K 1.45% 26
2017
Q2 		$1.42M Sell
17,211
-2
-0% -$163 1.54% 21
2017
Q1 		$1.45M Sell
17,213
-750
-4% -$60.1K 1.54% 26
2016
Q4 		$1.32M Sell
17,963
-2,125
-11% -$158K 1.38% 27
2016
Q3 		$1.61M Hold
20,088
– – 1.84% 17
2016
Q2 		$1.58M Buy
20,088
+4,440
+28% +$334K 1.88% 17
2016
Q1 		$1.13M Sell
15,648
-240
-2% -$18.2K 1.43% 25
2015
Q4 		$1.34M Sell
15,888
-320
-2% -$26.6K 1.69% 18
2015
Q3 		$1.36M Sell
16,208
-800
-5% -$67.5K 1.72% 17
2015
Q2 		$1.42M Sell
17,008
-9
-0.1% -$686 1.43% 24
2015
Q1 		$1.24M Hold
17,017
– – 1.26% 27
2014
Q4 		$1.17M Sell
17,017
-200
-1% -$13.5K 1.17% 28
2014
Q3 		$1.12M Buy
+17,217
New +$1.09M 1.14% 32

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Sippican Capital Advisors's LLY Position: Q2 2026 in Review

Sippican Capital Advisors reduced its Eli Lilly (LLY) stake by 1.9% in Q2 2026, selling an estimated $56.2K and leaving 2,769 shares worth $3.32M. The position accounts for 2.03% of the portfolio, ranked #8.

Sippican Capital Advisors first reported a position in LLY in Q3 2014 and has held it in 48 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sippican Capital Advisors held 2,769 shares of Eli Lilly worth $3.32M as of Q2 2026.
  • Sippican Capital Advisors sold 55 Eli Lilly shares in Q2 2026, an estimated $56.2K.
  • Eli Lilly made up 2.03% of Sippican Capital Advisors's portfolio in Q2 2026, its #8 holding.
  • Sippican Capital Advisors first reported a position in Eli Lilly in Q3 2014 and has held it in 48 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sippican Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.